Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Nov 5, 2016
    OPDP Sends Fifth Untitled Letter of 2016 Questioning Spanish Opinion Leader Video
  • Nov 4, 2016
    NEJM Perspective Calls for Federal Court Rejection of Caronia Decision
  • Nov 2, 2016
    Three Warner Chilcott Sales Managers Sentenced in Connection with Prior Authorization Scheme
  • Nov 1, 2016
    FDA Responds to Comments About Its Planned DTC Animation Studies
  • Oct 26, 2016
    U.K. Advertising Standards Authority Nixes Health Ad
  • Oct 24, 2016
    Allegedly Fraudulent Marketer of $12 Million in Pharmaceuticals Pleads Guilty to Wire Fraud
  • Oct 24, 2016
    CDRH Web Page Provides Information, Interactive Form for Reporting Alleged Regulatory Misconduct
  • Oct 24, 2016
    Medtech Companies Not Reviewing All Elements of Sales Compensation Plans
  • Oct 24, 2016
    What To Expect from the FDA Off-label Hearing Nov. 9-10
  • Oct 19, 2016
    CFSAN, FTC Issue Joint Warning Letter over Dietary Supplement Company’s Unsubstantiated Advertising
  • More

Good Clinical Practice

  • Jun 5, 2017
    CTTI Launches Project on Investigator Qualification
  • Jun 2, 2017
    Komen Launches Toll-free Breast Cancer Clinical Trials Helpline
  • Jun 1, 2017
    SACHRP Recommends Delaying Revised Common Rule Effective Date
  • May 31, 2017
    AAHRPP Requests Common Rule Revision Delay
  • May 30, 2017
    Nevada Governor Approves Bill Encouraging Trial Participation
  • May 28, 2017
    SACHRP Finds Incidental Findings Do Not Have To Be Handled the Same as Individual Research Results
  • May 28, 2017
    SACHRP Asks FDA to Better Define Clinical Investigation
  • May 24, 2017
    EMA Releases Guideline on Serious Breach Reporting
  • May 24, 2017
    ACRO Calls Right-to-Try Laws ‘Deeply Flawed’
  • May 20, 2017
    Bill Encouraging Trial Participation Approved by Nevada Legislature
  • More

U.S. Food Labeling

  • Sep 30,2010
    FDA Mulls Approval and Labeling of Biotech Salmon
  • Sep 30,2010
    POM Takes FTC to Court over New Substantiation Standard and Prior Approval of Claims
  • Sep 30,2010
    FDA Puts Industry on Notice with Two Warning Letters Targeting Antioxidant Claims
  • Sep 30,2010
    Product Recalls
  • Sep 30,2010
    Fiber Labeling Lawsuit Against General Mills and Kellogg Dismissed by Federal Judge
  • Aug 31,2010
    CSPI Urges Unilever To Remove 'All Natural' Claims From Ben & Jerry's Ice Cream Labels
  • Aug 31,2010
    Miami Juice Maker Gets Warning Letter for Long List of Misleading Claims on Web and Labels
  • Aug 31,2010
    Kellogg and General Mills United in Opposition To Color-Coded 'Traffic Light' FOP System
  • Aug 31,2010
    Courts Seek FDA Guidance on 'Natural' Claims For Beverages Containing HFCS
  • Aug 31,2010
    Product Recalls
  • More

FDA Regulation & Enforcement

  • Oct 28, 2019
    Revised Draft Guidance, Withdrawal of CPG Signal Tougher FDA Enforcement for Homeopathic Drugs
  • Oct 25, 2019
    House Bill Introduced To Remove Tax Deduction for Drug Ads, Other Promotional Activities
  • Oct 25, 2019
    Ky. Receives $17 Million Settlement Over Claims for Birth Control Drugs
  • Oct 24, 2019
    States Reach $700 Million Settlement With Reckitt Over Suboxone Marketing
  • Oct 24, 2019
    AMS Describes More Changes Ahead for Organic Program’s National List
  • Oct 21, 2019
    Court: Device Firm Must Give Relator Materials That Were Provided to Government Before DOJ Declined To Intervene
  • Oct 21, 2019
    Survey of Open Payment Data Finds Amount of Payments, Number of Physicians Holding Steady
  • Oct 21, 2019
    Mississippi Hospitals Sue Opioid Makers
  • Oct 21, 2019
    J&J, Ethicon To Pay $116 Million To Resolve Lawsuit Over Transvaginal Surgical Mesh Promotion
  • Oct 18, 2019
    Ninth Circuit: Device Defect Alone Does Not Show Violation of FDA Mandates, So Claims Are Preempted
  • More

Medical Devices

  • Mar 21, 2013
    FDA Can Access, Spend Higher MDUFA III User Fees Under FY 2013 Spending Measure Passed by Congress
  • Mar 13, 2013
    Draft Guidance for Third Party Review Accreditation Released
  • Mar 13, 2013
    Study Finds Improvements in Number, Speed of 510(k) Clearances
  • Mar 12, 2013
    FDA, FTC Threaten Cosmetic Contact Lens Marketers With Prosecution in Joint Enforcement E-mail
  • Mar 7, 2013
    Draft Guidance on Distinguishing Device Recalls From Enhancements Draws Questions, Criticism
  • Mar 5, 2013
    Draft Guidance Outlines Communications With FDA During Device Reviews
  • Feb 15, 2013
    FDA Finalizes HUD Designation Guidance
  • Feb 15, 2013
    FDA To Hold Workshop on ‘Accessible’ Labeling
  • Feb 14, 2013
    CDRH Warning Letter Targets Israeli Device Firm’s Marketing
  • Feb 6, 2013
    CMS Expands DMEPOS Competitive Bidding Program
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.